Literature DB >> 17694321

Myxoinflammatory fibroblastic sarcoma: investigations by comparative genomic hybridization of two cases and review of the literature.

Daniel Baumhoer1, Kathrin Glatz, Hans-Jürgen Schulten, László Füzesi, Renato Fricker, Christoph Kettelhack, Paula Hasenboehler, Martin Oberholzer, Gernot Jundt.   

Abstract

Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare low-grade sarcoma of the distal extremities characterized by a myxohyaline stroma, a dense inflammatory infiltrate and virocyte- and lipoblast-like giant cells. Up to now, only two cases have been investigated cytogenetically, showing complex and heterogeneous karyotypes, in part with supernumerary ring chromosomes. We characterized two further cases of MIFS immunohistochemically and performed comparative genomic hybridization as well as DNA image cytometry analyses. Both tumors showed the characteristic histomorphological pattern of MIFS and were positive for Vimentin and CD68. Moreover, both cases presented aberrant karyotypes including distinct DNA copy number changes involving chromosome 7 and disclosed DNA aneuploidy.

Entities:  

Mesh:

Year:  2007        PMID: 17694321     DOI: 10.1007/s00428-007-0480-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  16 in total

1.  [Acral myxoinflammatory fibroblastic sarcoma. Six cases of a tumor entity].

Authors:  H Ebhardt; H Kosmehl; D Katenkamp
Journal:  Pathologe       Date:  2001-03       Impact factor: 1.011

2.  Remote quantitation server for quality assurance in DNA ploidy analysis.

Authors:  G Haroske; W Meyer; F Theissig; K Schubert; K D Kunze
Journal:  Anal Quant Cytol Histol       Date:  1998-08       Impact factor: 0.302

3.  Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas.

Authors:  E A Montgomery; K O Devaney; T J Giordano; S W Weiss
Journal:  Mod Pathol       Date:  1998-04       Impact factor: 7.842

4.  Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes.

Authors:  I Lambert; M Debiec-Rychter; P Guelinckx; A Hagemeijer; R Sciot
Journal:  Virchows Arch       Date:  2001-05       Impact factor: 4.064

5.  Myxoinflammatory fibroblastic sarcoma: a tumor not restricted to acral sites.

Authors:  Vesna Jurcić; Andreja Zidar; Maria Delia Perez Montiel; Snjezana Frković-Grazio; Simon J Nayler; Kumarasen Cooper; Saul Suster; Janez Lamovec
Journal:  Ann Diagn Pathol       Date:  2002-10       Impact factor: 2.090

Review 6.  Case reports: acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review.

Authors:  Jason E Lang; Leslie Dodd; Salutario Martinez; Brian E Brigman
Journal:  Clin Orthop Relat Res       Date:  2006-04       Impact factor: 4.176

7.  Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet.

Authors:  J M Meis-Kindblom; L G Kindblom
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

Review 8.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

Authors:  O P Kallioniemi; A Kallioniemi; J Piper; J Isola; F M Waldman; J W Gray; D Pinkel
Journal:  Genes Chromosomes Cancer       Date:  1994-08       Impact factor: 5.006

9.  1997 ESACP consensus report on diagnostic DNA image cytometry. Part II: Specific recommendations for quality assurance. European Society for Analytical Cellular Pathology.

Authors:  F Giroud; G Haroske; A Reith; A Böcking
Journal:  Anal Cell Pathol       Date:  1998       Impact factor: 2.916

10.  1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology.

Authors:  G Haroske; F Giroud; A Reith; A Böcking
Journal:  Anal Cell Pathol       Date:  1998       Impact factor: 2.916

View more
  6 in total

1.  Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

Authors:  Cristina R Antonescu; Lei Zhang; G Petur Nielsen; Andrew E Rosenberg; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2011-06-29       Impact factor: 5.006

Review 2.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

3.  Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.

Authors:  Yu-Chien Kao; Valentina Ranucci; Lei Zhang; Yun-Shao Sung; Edward A Athanasian; David Swanson; Brendan C Dickson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-11       Impact factor: 6.394

Review 4.  A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases.

Authors:  Raffaele Lombardi; Elio Jovine; Nicola Zanini; Maria Cristina Salone; Marco Gambarotti; Alberto Righi; Alba Balladelli; Marco Colangeli; Michele Rocca
Journal:  Int Orthop       Date:  2013-09-06       Impact factor: 3.075

5.  Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.

Authors:  Jun Nishio
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

6.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.